1 insiders reported 3 Form 4 transactions for Nasus Pharma Ltd (NSRX) over the past 18 months (most recent 2026-06-22). Recent activity: Teleman Dan Benjamin (Chief Executive Officer) Buy 6,550 shares, Teleman Dan Benjamin (Chief Executive Officer) Buy 2,900 shares, Teleman Dan Benjamin (Chief Executive Officer) Buy 15,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Teleman Dan Benjamin | Chief Executive Officer | Buy | 6,550 | $20,305 |
| 2026-04-22 | Teleman Dan Benjamin | Chief Executive Officer | Buy | 2,900 | $10,904 |
| 2026-04-01 | Teleman Dan Benjamin | Chief Executive Officer | Buy | 15,000 | $30,600 |
来源：SEC Form 4 申报文件 · 截至 2026-06-22